Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients

A phase II study was undertaken to determine the safety of combining flutamide with gemcitabine, with response rate being the primary end point. Twenty-seven patients with histologically proven, previously untreated, unresectable pancreatic adenocarcinoma received gemcitabine, 1 g m(−2) intravenousl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Corrie, P, Mayer, A, Shaw, J, D'Ath, S, Blagden, S, Blesing, C, Price, P, Warner, N
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2002
Konular:
Clinical
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2364255/
https://ncbi.nlm.nih.gov/pubmed/12232752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600523
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller